Robert Chapman
Southern Methodist University(US)Oxford Health NHS Foundation Trust(GB)University of Nebraska Medical Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Global Cancer Incidence and Screening, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321(2006)495 cited
- → The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions(2016)341 cited
- → Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production11Abbreviations: CTLs, cytotoxic T lymphocytes; LAK cells, lymphokine activated killer cells; IL-2, interleukin-2; IFN-γ, interferon-gamma; TNF-α, tumor necrosis factor-α NF-κB, nuclear factor kappa B; Con A, concanavalin A; HBSS, Hanks’ balanced salt solution; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride; RT-PCR, reverse transcription-polymerase chain reaction; LPS, lipopolysaccharide; and EMSA, electrophoretic mobility shift assay.(2001)244 cited
- → Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages(1993)228 cited
- → Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid(2012)214 cited